SG Americas Securities
GUTS icon

SG Americas Securities’s Fractyl Health GUTS Stock Holding History

SG Americas Securities’s Portfolio GUTS Stock Details GUTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-13,188
Closed -$33K – 3700
2024
Q3 		$33K Buy
+13,188
New +$43K ﹤0.01% 3315

Other funds holding GUTS

DMC
Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return
HM
HCC Manager Chicago, Illinois $10.3M AUM 6.8% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

SG Americas Securities's GUTS Position: Q4 2024 in Review

SG Americas Securities sold out of Fractyl Health (GUTS) in Q4 2024, closing a stake of 13,188 shares — an estimated $33K sold.

SG Americas Securities first reported a position in GUTS in Q3 2024 and held it in 1 quarter. The position peaked at $33K in Q3 2024. 65 funds tracked by Wall St. Rank hold GUTS as of Q4 2024.

  • SG Americas Securities reported no remaining Fractyl Health position as of Q4 2024 after selling out during the quarter.
  • SG Americas Securities sold 13,188 Fractyl Health shares in Q4 2024, an estimated $33K.
  • SG Americas Securities first reported a position in Fractyl Health in Q3 2024 and held it in 1 quarter.
  • SG Americas Securities's Fractyl Health position peaked at $33K in Q3 2024.
  • 65 funds tracked by Wall St. Rank held Fractyl Health as of Q4 2024.

Based on SG Americas Securities's 13F filing for Q4 2024, filed 17 Jan 2025.